Cosma Spolka Akcyjna Logo

Cosma Spolka Akcyjna

Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.

COS | WAR

Overview

Corporate Details

ISIN(s):
PLVBN0000015 (+5 more)
LEI:
259400QHISD311JE0I22
Country:
Poland
Address:
WARSZAWA WOŁOSKA 22A, 02-675 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cosma S.A. is a company specializing in the development, production, and distribution of hemp-based products. The company's portfolio includes natural dietary supplements, such as its innovative Cosma Cannabis line of dual-phase capsules that combine phytocannabinoids with herbs, vitamins, and minerals. Cosma S.A. also develops and registers pharmaceutical raw materials, operating a wholesale business within the pharmaceutical sector. The company utilizes an integrated production chain to ensure high-quality, natural hemp extracts free of synthetic additives. It distributes its products through both traditional and online retail channels.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cosma Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cosma Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cosma Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Forte Biosciences, Inc. Logo
Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.
United States of America
FBRX
Fortress Biotech, Inc. Logo
Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.
United States of America
FBIO
FRACTYL HEALTH, INC. Logo
Developing gut-targeted endoscopic and gene therapies for obesity and type 2 diabetes.
United States of America
GUTS
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy
FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan
4554
Fulcrum Therapeutics, Inc. Logo
Develops gene-modulating small molecule drugs for rare, genetically defined diseases.
United States of America
FULC
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan
4881
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan
4538
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom
FUM
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea
220100

Talk to a Data Expert

Have a question? We'll get back to you promptly.